|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―Apr―02 |
B Cell Dynamics and Transitional B Cells in Long COVID |
Zoia R. Korobova, Natalia A. Arsentieva, Natalia E. Liubimova, Oleg K. Batsunov, Anastasia A. Butenko, Albina E. Kokoeva, et al. (+8) Natalia G. Kucherenko, Victor A. Kashchenko, Ekaterina V. Boeva, Anna O. Norka, Anastasia A. Knizhnikova, Vadim V. Rassokhin, Nikolay A. Belyakov, Areg A. Totolian |
2 |
[GO] |
2025―Mar―17 |
Structure-Based Identification of SARS-CoV-2 nsp10-16 Methyltransferase Inhibitors Using Molecular Dynamics Insights |
Ahmad M. Alharbi |
3 |
[GO] |
2025―Mar―12 |
Anti-Infective Screening of Selected Nine Cannabinoids Against Clostridium perfringens and Influenza A (H5N1) Neuraminidases, and SARS-CoV-2 Main Protease and Spike Protein Interactions |
Thanet Pitakbut, Oliver Kayser |
4 |
[GO] |
2025―Mar―11 |
The Legacy of COVID-19 in Breast Milk: The Association of Elevated Anti-Inflammatory and Antimicrobial Proteins with Vaccination or Infection |
Felicia Trofin, Petru Cianga, Daniela Constantinescu, Luminița Smaranda Iancu, Roxana Irina Iancu, Diana Păduraru, et al. (+5) Eduard Vasile Nastase, Elena Roxana Buzilă, Cătălina Luncă, Corina Maria Cianga, Olivia Simona Dorneanu |
5 |
[GO] |
2025―Feb―28 |
A Pilot Study on the Role of TRAFs in the Development of SARS-CoV-2 Infection Before and After Immunization with AstraZeneca Chadox1 in Mice |
Mounia Ammara, Inass Samiry, Younes Zaid, Mounia Oudghiri, Abdallah Naya |
6 |
[GO] |
2024―Nov―12 |
Computational Insights into Acrylamide Fragment Inhibition of SARS-CoV-2 Main Protease |
Ping Chen, Liyuan Wu, Bo Qin, Haodong Yao, Deting Xu, Sheng Cui, Lina Zhao |
7 |
[GO] |
2024―Nov―06 |
Benchmark Investigation of SARS-CoV-2 Mutants’ Immune Escape with 2B04 Murine Antibody: A Step Towards Unraveling a Larger Picture |
Karina Kapusta, Allyson McGowan, Santanu Banerjee, Jing Wang, Wojciech Kolodziejczyk, Jerzy Leszczynski |
8 |
[GO] |
2024―Oct―23 |
SARS-CoV-2 and Environmental Changes: The Perfect Storm |
Mario Caldarelli, Pierluigi Rio, Vincenzo Giambra, Ivana Palucci, Antonio Gasbarrini, Giovanni Gambassi, Rossella Cianci |
9 |
[GO] |
2024―Oct―22 |
Impact of Hyponatremia and ADH Secretion in MIS-C and COVID-19: An Integrative Approach of Prognostic and Diagnostic Markers |
Diana-Andreea Ciortea, Carmen Loredana Petrea (Cliveți), Sorin Ion Berbece, Silvia Fotea, Iolanda Cristina Vivisenco, Gabriela Gurău, et al. (+2) Mădălina Nicoleta Matei, Aurel Nechita |
10 |
[GO] |
2024―Oct―02 |
Enhanced RBD-Specific Antibody Responses and SARS-CoV-2-Relevant T-Cell Activity in Healthcare Workers Following Booster Vaccination |
Lina Souan, Hikmat Abdel-Razeq, Maher A. Sughayer |
11 |
[GO] |
2024―Aug―15 |
Dysregulated Inflammatory Cytokine Levels May Be Useful Markers in a Better Up-Dated Management of COVID-19 |
Marco Iuliano, Roberta Maria Mongiovì, Alberico Parente, Blerta Kertusha, Anna Carraro, Raffaella Marocco, et al. (+8) Giulia Mancarella, Cosmo Del Borgo, Laura Fondaco, Lorenzo Grimaldi, Maria Dorrucci, Miriam Lichtner, Giorgio Mangino, Giovanna Romeo |
12 |
[GO] |
2024―Aug―10 |
A New Case of Paediatric Systemic Lupus Erythematosus with Onset after SARS-CoV-2 and Epstein-Barr Infection-A Case Report and Literature Review |
Carmen Loredana Petrea (Cliveți), Diana-Andreea Ciortea, Magdalena Miulescu, Iuliana-Laura Candussi, Sergiu Ioachim Chirila, Gabriela Isabela Verga (Răuță), et al. (+3) Simona-Elena Bergheș, Mihai Ciprian Râșcu, Sorin Ion Berbece |
13 |
[GO] |
2024―Aug―06 |
Are COVID-19 Polymorphisms in ACE and ACE2 Prognosis Predictors? |
Fabiana Amaral Guarienti, Fernando Antônio Costa Xavier, Mateus Duarte Ferraz, Fernanda Wagner, Daniel Rodrigo Marinowic, Jaderson Costa da Costa, Denise Cantarelli Machado |
14 |
[GO] |
2024―Jul―10 |
Preliminary Study on the Restoration of the Phospholipid Profile in Serum from Patients with COVID-19 by Treatment with Vitamin E |
María Elena Soto, Linaloe Manzano-Pech, Verónica Guarner-Lans, Adrían Palacios-Chavarría, Rafael Ricardo Valdez-Vázquez, Raúl Martínez-Memije, et al. (+3) Mohammed El-Hafidi, Félix Leao Rodríguez-Fierros, Israel Pérez-Torres |
15 |
[GO] |
2024―Jun―28 |
Potential Protective Factors for Allergic Rhinitis Patients Infected with COVID-19 |
Jiaoyue Dong, Dingyuan Su, Binbin Zhao, Jiayang Han, Mengjie Tu, Kaifeng Zhang, et al. (+2) Fengling Wang, Yang An |
16 |
[GO] |
2024―Jun―21 |
MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development |
Farah Khaznadar, Omar Khaznadar, Ana Petrovic, Marija Hefer, Fabian Gjoni, Stefan Gjoni, et al. (+3) Justinija Steiner, Martina Smolic, Kristina Bojanic |
17 |
[GO] |
2024―Jun―10 |
Genomic Evolution Strategy in SARS-CoV-2 Lineage B: Coevolution of Cis Elements |
Yahaira de J. Tamayo-Ordóñez, Ninfa M. Rosas-García, Francisco A. Tamayo-Ordoñez, Benjamín A. Ayil-Gutiérrez, Juan M. Bello-López, Gerardo de J. Sosa-Santillán, et al. (+6) Erika Acosta-Cruz, Francisco Anguebes-Franseschi, Siprian Damas-Damas, Angel V. Domínguez-May, Atl Victor Córdova-Quiroz, María Concepción Tamayo-Ordóñez |
18 |
[GO] |
2024―May―10 |
SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer’s Disease |
George D. Vavougios, Theodoros Mavridis, Triantafyllos Doskas, Olga Papaggeli, Pelagia Foka, Georgios Hadjigeorgiou |
19 |
[GO] |
2024―May―06 |
Insights into the Activation of Unfolded Protein Response Mechanism during Coronavirus Infection |
Panagiotis Keramidas, Maria Pitou, Eleni Papachristou, Theodora Choli-Papadopoulou |
20 |
[GO] |
2024―May―03 |
Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves |
Panagiota Tsiatsiou, Kyriakos Kouirouxis, Vasiliki Tsaireli, Antonia Lanta, Angeliki Kassomenaki, Maria Papaioannou, et al. (+2) Efthymia Protonotariou, Lemonia Skoura |
21 |
[GO] |
2024―Apr―18 |
CCN1-Mediated Signaling in Placental Villous Tissues after SARS-CoV-2 Infection in Term Pregnant Women: Implications for Dysregulated Angiogenesis |
Yuyang Ma, Liyan Duan, Beatrix Reisch, Rainer Kimmig, Antonella Iannaccone, Alexandra Gellhaus |
22 |
[GO] |
2024―Feb―29 |
COVID-19 Associated Cardiovascular Disease-Risks, Prevention and Management: Heart at Risk Due to COVID-19 |
Andrew Kemerley, Abhishek Gupta, Mahesh Thirunavukkarasu, Monica Maloney, Sean Burgwardt, Nilanjana Maulik |
23 |
[GO] |
2024―Jan―25 |
Disruption of the Functional Activity of Neutrophil Granulocytes as a Risk Factor for the Development of Lung Damage in Pregnant Women with COVID-19 |
Irina Anatolyevna Andrievskaya, Egor Mikhailovich Ustinov, Karen Sargisovich Lyazgian, Nataliya Alexandrovna Ishutina, Inna Victorovna Dovzhikova |
24 |
[GO] |
2024―Jan―24 |
An Expeditious Neutralization Assay for Porcine Reproductive and Respiratory Syndrome Virus Based on a Recombinant Virus Expressing Green Fluorescent Protein |
Juan Wang, Jiecong Yan, Shuaiyong Wang, Ronglin Chen, Yanru Xing, Qingyan Liu, et al. (+12) Shuolei Gao, Yuxiang Zhu, Jiannan Li, Yanjun Zhou, Tongling Shan, Wu Tong, Hao Zheng, Ning Kong, Yifeng Jiang, Changlong Liu, Guangzhi Tong, Hai Yu |
25 |
[GO] |
2024―Jan―02 |
Single-Cell RNA Sequencing Reveals Alterations in Patient Immune Cells with Pulmonary Long COVID-19 Complications |
Kristīne Vaivode, Rihards Saksis, Helēna Daiga Litvina, Helvijs Niedra, Marta Līva Spriņģe, Una Krūmiņa, et al. (+2) Jānis Kloviņš, Vita Rovite |
26 |
[GO] |
2023―Dec―18 |
In Silico Analysis of SARS-CoV-2 Non-Structural Proteins Reveals an Interaction with the Host’s Heat Shock Proteins That May Contribute to Viral Replications and Development |
Mthembu Yamkela, Zingisa Sitobo, Xolani H. Makhoba |
27 |
[GO] |
2023―Sep―29 |
The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2 |
Simona Fenizia, Melania Gaggini, Cristina Vassalle |
28 |
[GO] |
2023―Sep―29 |
Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2 |
Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, Shimrit Adutler-Lieber, Liat Bar-On, Erez Bar-Haim, et al. (+6) Boaz Politi, Einat B. Vitner, Hadas Tamir, Sharon Melamed, Nir Paran, Tomer Israely |
29 |
[GO] |
2023―Aug―28 |
Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities |
Asif Mahmood, Shahid Mehmood, Wen Zhang |
30 |
[GO] |
2023―Jul―19 |
A Clinical Qualification Protocol Highlights Overlapping Genomic Influences and Neuro-Autonomic Mechanisms in Ehlers-Danlos and Long COVID-19 Syndromes |
Golder N. Wilson |
31 |
[GO] |
2023―Jul―14 |
Genome-Wide Mining of Selaginella moellendorffii for Hevein-like Lectins and Their Potential Molecular Mimicry with SARS-CoV-2 Spike Glycoprotein |
Ahmed Alsolami, Amina I. Dirar, Emadeldin Hassan E. Konozy, Makarim El-Fadil M. Osman, Mohanad A. Ibrahim, Khalid Farhan Alshammari, et al. (+3) Fawwaz Alshammari, Meshari Alazmi, Kamaleldin B. Said |
32 |
[GO] |
2023―Jul―03 |
Exploring Key Biomarkers and Common Pathogenesis of Seven Digestive System Cancers and Their Correlation with COVID-19 |
Zuming Xiong, Yongjun Yang, Wenxin Li, Yirong Lin, Wei Huang, Sen Zhang |
33 |
[GO] |
2023―May―08 |
Cycle Threshold (Ct) Values of SARS-CoV-2 Detected with the GeneXpert® System and a Mutation Associated with Different Target Gene Failure |
Keita Yamashita, Terumi Taniguchi, Noriyasu Niizeki, Yuki Nagao, Akira Suzuki, Akihiro Toguchi, et al. (+6) Shiori Takebayashi, Jinko Ishikawa, Osanori Nagura, Kazuki Furuhashi, Moriya Iwaizumi, Masato Maekawa |
34 |
[GO] |
2023―Apr―05 |
Host-Based Treatments for Severe COVID-19 |
Lucrezia Mondini, Francesco Salton, Liliana Trotta, Chiara Bozzi, Riccardo Pozzan, Mariangela Barbieri, et al. (+6) Stefano Tavano, Selene Lerda, Michael Hughes, Marco Confalonieri, Paola Confalonieri, Barbara Ruaro |
35 |
[GO] |
2023―Apr―04 |
Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review |
Michele Montori, Gialuca Svegliati Baroni, Pierangelo Santori, Catia Di Giampaolo, Francesca Ponziani, Ludovico Abenavoli, Emidio Scarpellini |
36 |
[GO] |
2023―Apr―04 |
Endogenous piRNAs Can Interact with the Omicron Variant of the SARS-CoV-2 Genome |
Aizhan Rakhmetullina, Aigul Akimniyazova, Togzhan Niyazova, Anna Pyrkova, Saltanat Kamenova, Aida Kondybayeva, et al. (+3) Alma-Gul Ryskulova, Anatoliy Ivashchenko, Piotr Zielenkiewicz |
37 |
[GO] |
2023―Mar―16 |
Immunohistochemical Analysis of Spermatogenesis in Patients with SARS-CoV-2 Invasion in Different Age Groups |
Grigory A. Demyashkin, Evgeniya Kogan, Tatiana Demura, Dmitry Boldyrev, Matvey Vadyukhin, Vladimir Schekin, et al. (+2) Peter Shegay, Andrey Kaprin |
38 |
[GO] |
2023―Mar―01 |
Biomarker Profiles Associated with COVID-19 Severity and Mortality |
Silvia Sánchez-Díez, Carlos Gómez-Ollés, María-Jesús Cruz, Miquel de Homdedeu, David Espejo, Jaume Ferrer, et al. (+3) Oriol Roca, Andrés Pacheco, Xavier Muñoz |
39 |
[GO] |
2023―Feb―10 |
Proof-of-Concept Analysis of B Cell Receptor Repertoire in COVID-19 Patients Undergoing ECMO by Single-Cell V(D)J and Gene Expression Sequencing |
Alessia Gallo, Nicola Cuscino, Claudia Carcione, Rosalia Busà, Pier Giulio Conaldi, Matteo Bulati |
40 |
[GO] |
2023―Feb―08 |
Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Cl믭 Pyridine Scaffolds as Potential COVID-19 Inhibitors |
Adel Alghamdi, Amr S. Abouzied, Abdulwahab Alamri, Sirajudheen Anwar, Mukhtar Ansari, Ibrahim Khadra, et al. (+2) Yasser H. Zaki, Sobhi M. Gomha |
41 |
[GO] |
2023―Jan―20 |
Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients |
Hasan Doğan, Aslı Kara, Erdem Çankaya, Eda Balkan, Muhammet Ali Gürbüz, Murat Kızılkaya, Merve Aykaç |
42 |
[GO] |
2023―Jan―12 |
In Vitro Antiviral Evaluations of Coldmix®: An Essential Oil Blend against SARS-CoV-2 |
Kemal Hüsnü Can Başer, Ayşe Esra Karadağ, Sevde Nur Biltekin, Murat Ertürk, Fatih Demirci |
43 |
[GO] |
2023―Jan―05 |
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors |
Desh Deepak Singh, Ihn Han, Eun-Ha Choi, Dharmendra Kumar Yadav |
44 |
[GO] |
2023―Jan―02 |
Severe Acute Respiratory Syndrome Coronavirus-2 Delta Variant Study In Vitro and Vivo |
Hranush Avagyan, Sona Hakobyan, Arpine Poghosyan, Lina Hakobyan, Liana Abroyan, Elena Karalova, et al. (+6) Aida Avetisyan, Mariam Sargsyan, Bagrat Baghdasaryan, Nane Bayramyan, Diana Avetyan, Zaven Karalyan |
45 |
[GO] |
2023―Jan―02 |
Increased mTOR Signaling and Impaired Autophagic Flux Are Hallmarks of SARS-CoV-2 Infection |
Érika Pereira Zambalde, Thomaz Luscher Dias, Grazielle Celeste Maktura, Mariene R. Amorim, Bianca Brenha, Luana Nunes Santos, et al. (+17) Lucas Buscaratti, João Gabriel de Angeli Elston, Mariana Camargo Silva Mancini, Isadora Carolina Betim Pavan, Daniel A. Toledo-Teixeira, Karina Bispo-dos-Santos, Pierina L. Parise, Ana Paula Morelli, Luiz Guilherme Salvino da Silva, Ícaro Maia Santos de Castro, Tatiana D. Saccon, Marcelo A. Mori, Fabiana Granja, Helder I. Nakaya, Jose Luiz Proenca-Modena, Henrique Marques-Souza, Fernando Moreira Simabuco |
46 |
[GO] |
2022―Dec―21 |
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19 |
Jenny Valentina Garmendia, Alexis Hipólito García, Claudia Valentina De Sanctis, Marián Hajdúch, Juan Bautista De Sanctis |
47 |
[GO] |
2022―Dec―21 |
The Potential of Stilbene Compounds to Inhibit Mpro Protease as a Natural Treatment Strategy for Coronavirus Disease-2019 |
Ayesha Naseem, Fatima Rasool, Abrar Ahmed, Wayne G. Carter |
48 |
[GO] |
2022―Nov―28 |
Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer |
Takuma Hayashi, Kenji Sano, Nobuo Yaegashi, Ikuo Konishi |
49 |
[GO] |
2022―Nov―16 |
Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma |
Ihn Han, Sohail Mumtaz, Sekar Ashokkumar, Dharmendra Kumar Yadav, Eun Ha Choi |
50 |
[GO] |
2022―Oct―30 |
Increased Levels of Autoantibodies against ROS-Modified Proteins in Depressed Individuals with Decrease in Antibodies against SARS-CoV-2 Antigen (S1-RBD) |
Subuhi Sherwani, Mohamed Raafat, Saravanan Rajendrasozhan, Mahvish Khan, Mohd Saleem, Qayyum Husain, et al. (+3) Saif Khan, Noor Alam, Mohd Wajid Ali Khan |
51 |
[GO] |
2022―Oct―20 |
Targeting Natural Plant Metabolites for Hunting SARS-CoV-2 Omicron BA.1 Variant Inhibitors: Extraction, Molecular Docking, Molecular Dynamics, and Physicochemical Properties Study |
Heba Ali Hassan, Ahmed R. Hassan, Eslam A. R. Mohamed, Ahmad Al-Khdhairawi, Hala E. Taha, Hanan M. El-Tantawy, et al. (+10) Iman A. M. Abdel-Rahman, Ali E. Raslan, Khaled S. Allemailem, Ahmad Almatroudi, Faris Alrumaihi, Maha A. Alshiekheid, Hafiz Muzzammel Rehman, Mahmoud M. Abdelhamid, Islam M. Abdel-Rahman, Ahmed E. Allam |
52 |
[GO] |
2022―Oct―12 |
Era of Molecular Diagnostics Techniques before and after the COVID-19 Pandemic |
Ahmad M. Alamri, Faris A. Alkhilaiwi, Najeeb Ullah Khan |
53 |
[GO] |
2022―Oct―11 |
Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against? |
Maamoun Basheer, Elias Saad, Majd Kananeh, Layyous Asad, Osama Khayat, Anan Badarne, et al. (+6) Zaki Abdo, Nada Arraf, Faris Milhem, Tamara Bassal, Mariana Boulos, Nimer Assy |
54 |
[GO] |
2022―Sep―30 |
Synthesis and In Silico Study of Some New bis-[1,3,4]thiadiazolimines and bis-Thiazolimines as Potential Inhibitors for SARS-CoV-2 Main Protease |
Sobhi M. Gomha, Sayed M. Riyadh, Magda H. Abdellattif, Tariq Z. Abolibda, Hassan M. Abdel-aziz, AbdElAziz. A. Nayl, et al. (+2) Alaa M. Elgohary, Abdo A. Elfiky |
55 |
[GO] |
2022―Jul―22 |
COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B |
Salvador García-Carmona, Ramcés Falfán-Valencia, Abigail Verónica-Aguilar, Ivette Buendía-Roldán, Leslie Chávez-Galán, Rafael de Jesús Hernández-Zenteno, et al. (+11) Alfonso Martínez-Morales, Ingrid Fricke-Galindo, Jesús Alanis-Ponce, Daniela Valencia-Pérez Rea, Ilse Adriana Gutiérrez-Pérez, Oscar Zaragoza-García, Karol J. Nava-Quiroz, Angel Camarena, Mayra Mejía, Iris Paola Guzmán-Guzmán, Gloria Pérez-Rubio |
56 |
[GO] |
2022―Jul―04 |
Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study |
Ahmad F. Eweas, Hosam-Eldin H. Osman, Ibrahim A. Naguib, Mohammed A. S. Abourehab, Ahmed S. Abdel-Moneim |
57 |
[GO] |
2022―Jun―29 |
Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection |
Eleni Gavriilaki, Stefanos A. Tsiftsoglou, Tasoula Touloumenidou, Evangelia Farmaki, Paraskevi Panagopoulou, Elissavet Michailidou, et al. (+17) Evaggelia-Evdoxia Koravou, Ioulia Mavrikou, Elias Iosifidis, Olga Tsiatsiou, Eleni Papadimitriou, Efimia Papadopoulou-Alataki, Penelope Georgia Papayanni, Christos Varelas, Styliani Kokkoris, Apostolia Papalexandri, Maria Fotoulaki, Assimina Galli-Tsinopoulou, Dimitrios Zafeiriou, Emmanuel Roilides, Ioanna Sakellari, Achilles Anagnostopoulos, Athanasios Tragiannidis |
58 |
[GO] |
2022―Jun―29 |
The Occluded Epitope Residing in Spike Receptor-Binding Motif Is Essential for Cross-Neutralization of SARS-CoV-2 Delta Variant |
Weeraya Thongkum, Kanyarat Thongheang, Chatchai Tayapiwatana |
59 |
[GO] |
2022―May―10 |
Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients |
Maura D’Amato, Valentina Vertui, Laura Pandolfi, Sara Bozzini, Tommaso Fossali, Riccardo Colombo, et al. (+6) Anna Aliberti, Marco Fumagalli, Paolo Iadarola, Camilla Didò, Simona Viglio, Federica Meloni |
60 |
[GO] |
2022―Apr―20 |
Revealing Potential Bioactive Compounds and Mechanisms of Lithospermum erythrorhizon against COVID-19 via Network Pharmacology Study |
Ki-Kwang Oh, Md. Adnan |
61 |
[GO] |
2022―Apr―12 |
Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115-1126 |
Hamid A. Merchant |
62 |
[GO] |
2022―Apr―08 |
Network Pharmacology Study to Elucidate the Key Targets of Underlying Antihistamines against COVID-19 |
Ki-Kwang Oh, Md. Adnan, Dong-Ha Cho |
63 |
[GO] |
2022―Feb―28 |
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line |
Markus Aldén, Francisko Olofsson Falla, Daowei Yang, Mohammad Barghouth, Cheng Luan, Magnus Rasmussen, Yang De Marinis |
64 |
[GO] |
2022―Feb―07 |
Transcription of the Envelope Protein by 1-L Protein-RNA Recognition Code Leads to Genes/Proteins That Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis |
Jozef Nahalka |
65 |
[GO] |
2022―Jan―11 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mutational Pattern in the Fourth Pandemic Phase in Greece |
Panagiotis Halvatsiotis, Sofia Vassiliu, Panagiotis Koulouvaris, Kalliopi Chatzantonaki, Konstantinos Asonitis, Ekatherina Charvalos, et al. (+2) Argyris Siatelis, Dimitra Houhoula |
66 |
[GO] |
2022―Jan―06 |
Possibility of SARS-CoV-2 Infection in the Metastatic Microenvironment of Cancer |
Takuma Hayashi, Kenji Sano, Ikuo Konishi |
67 |
[GO] |
2021―Dec―31 |
Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents |
Igor V. Kudryavtsev, Natalia A. Arsentieva, Oleg K. Batsunov, Zoia R. Korobova, Irina V. Khamitova, Dmitrii V. Isakov, et al. (+10) Raisa N. Kuznetsova, Artem A. Rubinstein, Oksana V. Stanevich, Aleksandra A. Lebedeva, Evgeny A. Vorobyov, Snejana V. Vorobyova, Alexander N. Kulikov, Maria A. Sharapova, Dmitrii E. Pevtcov, Areg A. Totolian |
68 |
[GO] |
2021―Dec―22 |
Protective Effect of Melatonin Administration against SARS-CoV-2 Infection: A Systematic Review |
Antonio Molina-Carballo, Rafael Palacios-López, Antonio Jerez-Calero, María Carmen Augustín-Morales, Ahmed Agil, Antonio Muñoz-Hoyos, Antonio Muñoz-Gallego |
69 |
[GO] |
2021―Nov―18 |
A Comparative Study between Spanish and British SARS-CoV-2 Variants |
Jose A. Jimenez Ruiz, Cecilia Lopez Ramirez, Jose Luis Lopez-Campos |
70 |
[GO] |
2021―Nov―08 |
Strategy to Develop and Evaluate a Multiplex RT-ddPCR in Response to SARS-CoV-2 Genomic Evolution |
Laura A. E. Van Poelvoorde, Mathieu Gand, Marie-Alice Fraiture, Sigrid C. J. De Keersmaecker, Bavo Verhaegen, Koenraad Van Hoorde, et al. (+4) Ann Brigitte Cay, Nadège Balmelle, Philippe Herman, Nancy Roosens |
71 |
[GO] |
2021―Sep―23 |
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis |
Katie-May McLaughlin, Denisa Bojkova, Joshua D. Kandler, Marco Bechtel, Philipp Reus, Trang Le, et al. (+7) Florian Rothweiler, Julian U. G. Wagner, Andreas Weigert, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Cinatl |
72 |
[GO] |
2021―Aug―02 |
Next-Generation Sequencing (NGS) in COVID-19: A Tool for SARS-CoV-2 Diagnosis, Monitoring New Strains and Phylodynamic Modeling in Molecular Epidemiology |
Goldin John, Nikhil Shri Sahajpal, Ashis K. Mondal, Sudha Ananth, Colin Williams, Alka Chaubey, et al. (+2) Amyn M. Rojiani, Ravindra Kolhe |
73 |
[GO] |
2021―Jul―20 |
Coronavirus Disease 2019 (COVID-19) Diagnostic Tools: A Focus on Detection Technologies and Limitations |
Ahmad Qasem, Ameera M. Shaw, Erij Elkamel, Saleh A. Naser |